Summary.-Tumour-associated prostaglandin-like material, assessed by bioassay, has been examined in 37 patients with primary and metastatic squamous carcinomas of the head and neck, previously treated by radiotherapy and chemotherapy followed by radical surgery. High amounts of prostaglandin-like material were extracted from tumours excised within 3 months of radiotherapy and chemotherapy. These amounts correlated with necrosis, inflammation and fibrosis, but not with tumour site, size or degree of differentiation. Most of the prostaglandins formed by these treated tumours thus seem to be associated with host stromal and inflammatory cells, rather than the neoplastic cells. The possible roles of prostaglandins in facilitating the spread of squamous carcinomas are discussed.
THE AMOUNTS OF PROSTAGLANDINS extracted from various tumours, notably from human carcinomas of the breast (Bennett et al., 1975 Powles et al., 1976) , large intestine (Bennett et al., 1977) and kidney (Atkins et al., 1977) and from certain experimental neoplasms (Powles et al., 1 973; Tashjian et al., 1974; Galasko, 1.976; Galasko & Bennett, 1976) are usually greater than from the corresponding normal tissues. Prostaglandins and other lessclearly defined "tumour-associated" products may be involved in the establishment and growth of metastases in bone and possibly in other sites (Carter, 1978; Bennett, 1979) . Prostaglandin E2 (PGE2) and some other prostanoids stimulate osteoclasts (Galasko, 1976; Carter, 1978; Bennett, 1979) and the recent observation of pronounced osteoclastic activity associated with squamous carcinomas of the head and neck invading bone (Carter & Tanner, 1979; Carter et al., 1980) prompted the present investigation.
PATIENTS AND METHODS
Studies were made on 37 patients from the Royal Marsden and King's College Hospitals wN-ith histologically proven squamous carcinomas of the head and neck. There wNere 32 males and 5 females, aged between 27 and 70 years (median 59). Large (T3, T4) tumours predominated. The sites of the primary carcinomas were as follows: larynx 11, tongue 10, oral cavity (lip, floor of mouth, alveolus, soft palate, buccal mucosa) 8, oropharynx 5, nose and paranasal sinuses 2, hypopharynx 1, and external auditory meatus 1. One patient had two primary carcinomas (oropharynx and oral cavity). All patients had been previously treated, either by radiotherapy (10) or by combined radiotherapy and chemotherapy (27) , 1 to 80 months (median 3 months) before radical surgery. The radiotherapy given was from a Cobalt-60 unit at fractions of 200 rad over about 6 weeks, to a final dose of between 4,000 and 8,000 rad (median 6,000 rad). Chemotherapy, given either before or synchronized with radiotherapy, consisted of combinations of vincristine, bleomycin, methotrexate and 5-fluorouracil (O'Connor et al., 1977; Price & Hill, 1977) .
Prostaglandin-like material was extracted from residual or locally recurrent primary carcinomas and from cervical lymphnode metastases. Irradiated but macroscopically normal mucosa from a distant resection line, and uninvolved lymph nodes, served as con-trol tissues. In 14 patients blood from the antecubital vein and the internal jugular vein was sampled at the time of surgery, for prostaglandin assay. Swabs for routine bacteriological culture were taken from all excised tumours. A part of each specimen taken for prostaglandin assay, and the remainder of the surgical specimen, were examined by standard histopathological procedures.
Tissues for assay were collected in dry, sterile containers and sent to the laboratory within 1 h of removal. They were then cut into small pieces with scissors and washed with Krebs' solution. Weighed samples were homogenized either in Krebs' solution to estimate prostaglandin-synthesizing ability, or in acidified aqueous ethanol to determine "basal" prostaglandins (Bennett et al., 1973) . Amounts synthesized from endogenous prostaglandin precursors released during homogenization were estimated by subtracting "basal" amounts from the "total" extracted from the homogenate in Krebs' solution (Unger et al., 1971) . The extracted material was assayed against PGE2, using the rat gastric fundus strip preparation treated with various antagonists which increase the selectivity and sensitivity of the assay (Bennett et al., 1973) . Tentative characterization of the prostaglandin-like material extracted from 14 tumour homogenates was made by chromatography, using paper impregnated with silica gel, and the solvent system for group separation of PGE and PGF compounds (Stamford & Unger, 1972) . Samples of venous blood were collected in lithium heparin tubes containing indomethacin (final concentration 10 ,tg/ml blood) and the prostaglandins extracted from the plasma (Unger et al., 1971) . The assay results are expressed as ng PGE2 equivalents/g fresh tissue (median and semiquartile ranges) and analysed statistically by the Mann-Whitney U test or by Spearman's rank correlation.
RESULTS
Seventy assays of prostaglandin-like material were made on 33 primary squamous carcinomas, 9 lymphnode metastases and 28 control specimens of uninvolved mucosa -and lymph nodes. All the tissues had been previously irradiated, and those which were infected (as shown There was no consistent difference between the amounts of prostaglandins extracted from the peripheral venous blood (antecubital vein) of 12 patients and the blood draining the tumour-bearing area (internal jugular vein).
1)ISCUSSION
The methods used here do not permit exact identification and quantitation of the individual prostaglandins. Indeed, there is no technique available which can do this with all the lipid derivatives in the small amounts of tumour available for study. Our bioassay measures the ability of relatively stable extracted lipids to contract rat gastric fundus, but underestimates substances with low biological activity on this tissue. Clearly the amounts of assayed biological activity are higher in extracts of treated primary squamous carcinomas of the head and neck than of nodal metastases or normal tissue. The morphological findings indicate that these high amounts of prostaglandins correlate with necrosis, inflammation and fibrosis in and around the primary tumour rather than with more specific attributes of the tumour itself, such as its site, size and degree of differentiation. Necrosis, inflammation and related changes are likely to be more pronounced after irradiation and chemotherapy, and total amounts of prostaglandins were often higher in tumours removed within 3 months of such treatment. Various forms of local damage, including ionizing radiation (Eisen & Walker, 1976) can increase the amounts of prostaglandin in tissue.
Much of the prostaglandins extracted from treated primary squamous carcinomas of the head and neck may reflect the activity of host stromal and inflammatory cells particularly macrophages (Myatt et al., 1975; Humes et al., 1977; Carter, 1978; Bennett, 1979) There was no evidence of prostaglandin release from the tumours into the blood. If prostaglandin E or F compounds had been released, the levels of PG-like material in plasma from the internal jugular vein would be higher than in peripheral venous plasma since most of the prostaglandin E or F compounds liberated from the tumour would be inactivated in the pulmonary circulation. On the other hand, any prostaglandin released from these treated tumours would inevitably be diluted by blood from other regions of the head and neck, and may therefore have been undetectable in our bioassay. Many breast tumours release prostaglandin-like material into the blood (Stamford et al., 1979) and recalculation of data from a previous report (Mortel et al., 1977) suggest that prostaglandins are released from some pelvic carcinomas (Bennett, 1979) . In addition, recent work from our department (Tanner et al., unpublished) has shown an association between increased levels of prostaglandin-like material in peripheral venous plasma and the degree of radiation-induced mucositis, a complication which severely limits effective radiotherapy.
Since all the tumours examined here had been previously treated, it is not appropriate to compare the results with those obtained with untreated human tumours of other types. This may explain the absence of a correlation between tumour prostaglandins and patient survival (cf. Bennett et al., 1979) though the numbers of patients here are small. Nevertheless, prostaglandins associated with osteolytic primary squamous carcinomas of the head and neck may facilitate the direct spread of strategically placed tumours to adjacent bone or ossified cartilage (Carter et al., 1980; Carter & Tanner, 1979) .
Several studies in laboratory animals
have demonstrated benefits of using prostaglandin synthesis inhibitors in the treatment of malignant disease (Bennett, 1979) , and a trial is now in progress at King's College Hospital to evaluate flurbiprofen in the clinical management of patients with advanced (T3, T4) squamous carcinomas of the head and neck who are initially treated by radiotherapy (with or without chemotherapy) before planned radical surgery.
